Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11279688 Inhibitors of RET

Patent 11279688 was granted and assigned to Blueprint Medicines on March, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11993613 Thiazolo[5,4-b]pyridine MALT-1 inhibitors
0
Edits on 24 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11963958 RET inhibitor for use in treating cancer having a RET alteration
0
Edits on 19 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11872192 RET inhibitor for use in treating cancer having a RET alteration
0
Edits on 19 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1127968800
Edits on 30 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 30 Apr, 2023
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Edits on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Edits on 22 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Blueprint Medicines
Blueprint Medicines
0
Current Assignee
Blueprint Medicines
Blueprint Medicines
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112796880
Date of Patent
March 22, 2022
0
Patent Application Number
167756460
Date Filed
January 29, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=112796880
Patent Citations
‌
US Patent 10000490 Inhibitors of the fibroblast growth factor receptor
0
‌
US Patent 10000496 Compositions useful for treating disorders related to kit and PDGFR
0
‌
US Patent 10017512 Compounds and compositions useful for treating disorders related to NTRK
0
‌
US Patent 10030005 Inhibitors of RET
0
‌
US Patent 10035789 Compounds useful for treating disorders related to RET
0
‌
US Patent 10183928 Inhibitors of RET
0
‌
US Patent 10196436 Inhibitors of the fibroblast growth factor receptor
0
‌
US Patent 10202365 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
0
‌
US Patent 10221154 Inhibitors of the fibroblast growth factor receptor
0
‌
US Patent 10227329 Compounds useful for treating disorders related to RET
0
‌
US Patent 10584114 Inhibitors of RET
0
‌
US Patent 10774070 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
0
Patent Primary Examiner
‌
Brian E McDowell
0
CPC Code
‌
C07D 239/36
0
‌
C07D 239/30
0
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 22 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Blueprint Medicines
Blueprint Medicines
0
Current Assignee
Blueprint Medicines
Blueprint Medicines
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112796880
Date of Patent
March 22, 2022
0
Patent Application Number
167756460
Date Filed
January 29, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=112796880
Patent Citations
‌
US Patent 10000490 Inhibitors of the fibroblast growth factor receptor
0
‌
US Patent 10000496 Compositions useful for treating disorders related to kit and PDGFR
0
‌
US Patent 10017512 Compounds and compositions useful for treating disorders related to NTRK
0
‌
US Patent 10030005 Inhibitors of RET
0
‌
US Patent 10035789 Compounds useful for treating disorders related to RET
0
‌
US Patent 10183928 Inhibitors of RET
0
‌
US Patent 10196436 Inhibitors of the fibroblast growth factor receptor
0
‌
US Patent 10202365 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
0
‌
US Patent 10221154 Inhibitors of the fibroblast growth factor receptor
0
‌
US Patent 10227329 Compounds useful for treating disorders related to RET
0
‌
US Patent 10584114 Inhibitors of RET
0
‌
US Patent 10774070 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
0
Patent Primary Examiner
‌
Brian E McDowell
0
CPC Code
‌
C07D 239/36
0
‌
C07D 239/30
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11279688
Edits on 23 Mar, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 23 Mar, 2022
Edits made to:
Infobox (+23 properties)
Article (+192 characters)
‌

 US Patent 11279688 Inhibitors of RET

Article

Described herein are compounds that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.

Infobox
Is a
Patent
Patent
Patent applicant
Blueprint Medicines
Blueprint Medicines
Current assignee
Blueprint Medicines
Blueprint Medicines
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11279688
Date of patent
March 22, 2022
Patent application number
16775646
Date Filed
January 29, 2020
Patent citations
‌
US Patent 10000490 Inhibitors of the fibroblast growth factor receptor
‌
US Patent 10000496 Compositions useful for treating disorders related to kit and PDGFR
‌
US Patent 10017512 Compounds and compositions useful for treating disorders related to NTRK
‌
US Patent 10030005 Inhibitors of RET
‌
US Patent 10035789 Compounds useful for treating disorders related to RET
‌
US Patent 10183928 Inhibitors of RET
‌
US Patent 10196436 Inhibitors of the fibroblast growth factor receptor
‌
US Patent 10202365 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
‌
US Patent 10221154 Inhibitors of the fibroblast growth factor receptor
‌
US Patent 10227329 Compounds useful for treating disorders related to RET
‌
US Patent 10584114 Inhibitors of RET
‌
US Patent 10774070 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
Patent primary examiner
‌
Brian E McDowell
CPC Code
‌
C07D 239/36
‌
C07D 239/30

Find more entities like US Patent 11279688 Inhibitors of RET

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo